Performance Status News Today : Breaking News, Live Updates & Top Stories | Vimarsana

been diagnosed with cancer and is postponing public duties. he left the hospital a week ago after treatment for an enlarged prostate. joining us is nbc's molly hunter. i understand the palace has just released a statement. what are they saying? >> chris, that's right. we just got the statement. i'm just reading it for the first time as well. the big thing to understand, as you know, we covered the king's health scare last week which was really presented as a routine procedure. he was only in the hospital for three nights. he was in the london clinic right here in central london. righ...

Verastem Oncology announced the initial interim safety and efficacy results from the ongoing RAMP 205 Phase 1/2 clinical trial evaluating avutometinib plus defactinib in combination with gemcitabine...

Explore dosing nuances and adverse event management strategies for afatinib in treating EGFR mutant non-small cell lung cancer, reflecting real-world practices and clinical insights.

Leading oncologists discuss advanced treatment options for patients with progressing renal cell carcinoma (RCC), focusing on the promising results from LITESPARK-005 and treatment sequencing strategies.

Expert perspectives on the decision-making process for selecting frontline systemic therapy for patients with advanced renal cell carcinoma.